GreenWay Herbal Products announced Thursday the launch of Tanasi, a university-developed cannabis full-spectrum product line using a patent-pending CBDA/CBD formula.
“The CBDA is present in the raw plant material, and is the acidic precursor to CBD. The combination of CBDA/CBD is the basis, and difference maker, of our Tanasi product line. Two compounds work better than one, and we believe our products work better than CBD alone,” CEO Jeff Heeren said in a press release.
The entire Tanasi CBD patent-pending line contains 0.3% THC or less. All products are non-psychoactive and third-party tested.
The Entire line includes:
- Tinctures: Hemp extract from Cannabis Sativa L. CBDA/CBD formula, cannabinoids, and terpenes, combined with MCT oil.
- Capsules: Vegan HPMC capsules containing hemp extract from Cannabis Sativa L. that contains CBDA/CBD formula, cannabinoids, and terpenes, combined with MCT oil and sunflower oil.
- Lotion & Salve: both water and oil based
GreenWay Herbal Products declared activities related to its 10-year, $2.5 million university-licensing research agreement.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!